Immunology of hepatocellular carcinoma.
The immune surveillance theory continues to remain a powerful force in cancer research and therapy despite the varying degrees of enthusiasm from both its supporters and critics. The role of both specific and non-specific immune responses in the host's defense against hepatocellular carcinoma is presented as well as the possibilities of immune-system manipulation for the prevention and therapy of this tumour.
Paroli
M
M
Fondazione Andrea Cesalpino, I Clinica Medica, Università La Sapienza,Roma, Italy.
Perrone
A
A
Bonavita
M S
MS
Barnaba
V
V
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000276:immunology* / Q000628:therapy; D016207:Cytokines / Q000627:therapeutic use; D006801:Humans; D007157:Immunologic Surveillance; D016219:Immunotherapy, Adoptive / Q000379:methods*; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation; D008113:Liver Neoplasms / Q000276:immunology* / Q000628:therapy; D016246:Lymphocytes, Tumor-Infiltrating / Q000637:transplantation; D014611:Vaccination
D000911:Antibodies, Monoclonal; D016207:Cytokines